In comparison to normal ECM, tumor stroma exhibits increased richness, density, and stiffness, undergoing various alterations such as deposition, degradation, and post-translational modifications.527 One effective strategy involves targeting lysyl oxidase (LOX), an enzyme commonly upregulated in various cancers that facilitates collagen cross-linking. Here, LOX is linked to cancer.